Syntex adjuvant formulation.
Allison
A C
AC
Institute of Immunology and Biological Science, Syntex Research, Palo Alto, CA.
Byars
N E
NE
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000031:analogs & derivatives* / Q000138:chemical synthesis / Q000494:pharmacology; D000276:Adjuvants, Immunologic / Q000138:chemical synthesis* / Q000494:pharmacology; D000818:Animals; D004655:Emulsions / Q000138:chemical synthesis / Q000494:pharmacology; D006801:Humans; D011060:Poloxalene / Q000494:pharmacology; D011136:Polysorbates / Q000138:chemical synthesis / Q000494:pharmacology*; D013185:Squalene / Q000031:analogs & derivatives* / Q000138:chemical synthesis / Q000494:pharmacology; D014612:Vaccines / Q000276:immunology
D000276:Adjuvants, Immunologic; D004655:Emulsions; D011136:Polysorbates; C077975:Syntex adjuvant formulation; D014612:Vaccines; D000119:Acetylmuramyl-Alanyl-Isoglutamine; D013185:Squalene; D011060:Poloxalene